89Zr-J591
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 89Zr-J591, covering 2019-03-19 to 2019-03-19. Get the full timeline:
Most recent: Clinical Trial Update: 89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme [NA]